Video & Transcript DataContr Research : 'FDA'

Page 4 of 8
TX

Texas 2025 - 89th Regular

Health and Human Services Apr 1st, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • marker="46" data-time="270">Time after time, patients who exercised informed consent about the use of FDA-approved
  • are in a country where there's a right to try, and as long as a medication has been approved by the FDA
  • We weren't trained to think you can only prescribe a medication if it's indicated for use by the FDA.
  • They're using the FDA as an excuse to block prescriptions.
Summary: The meeting centered on multiple significant legislative proposals aimed at healthcare reforms, notably focused on the operations of pharmacy benefit managers (PBMs) and their impact on local pharmacies. Senator Hughes led the discussion on SB1236, which aims to regulate PBMs to prevent anti-competitive practices that have led to the closure of numerous community pharmacies. Testimonies from various stakeholders, including pharmacists, highlighted the challenges posed by current PBM practices, such as aggressive audit tactics and contract terms that disadvantage small pharmacies. The bill was generally supported in the committee due to its potential to restore balance and fairness in pharmacy operations.
US
Transcript Highlights:
  • with your offices certainly to explain both the impacts of previous and future decisions within the FDA
  • Just be able to ask, you know, when it comes to the FDA, what your thoughts are in terms of how we consider
  • Just the lack of protections for probationary employees in terms of how they were terminated at the FDA
Summary: The committee meeting focused on several nominees within key financial institutions, including discussions surrounding the SEC, the Federal Transit Administration, and the Comptroller of the Currency. Notable dialogue included concerns over regulatory balance, with various members emphasizing a need to streamline regulations to foster innovation while ensuring accountability and safety for investors. The importance of the proposed 'Empowering Main Street in America Act' was highlighted as a means to facilitate access to capital for small businesses, underlining the current administration's approach towards financial regulations.
TX

Texas 2025 - 89th 1st C.S.

State Affairs Aug 11th, 2025

Senate State Affairs Committee

Transcript Highlights:
  • numbers to back this up, and when the abortion pill was first introduced, this two-pill regimen, the FDA
  • Came out in the 1980s, indications that are FDA-approved

  • On that, but that is an FDA-approved indication for the
Bills: SB10, SB16, SB6
Summary: The committee meeting featured discussions on several key legislative issues, particularly focusing on human trafficking and related victim protections. Notably, Senate Bill 10 was presented by Senator Parker, aiming to provide an affirmative defense for victims of trafficking charged with crimes committed under coercion. The bill garnered significant support as witnesses provided personal testimonies highlighting the struggles faced by survivors, emphasizing the need for legal recognition of their circumstances. Additionally, Senate Bill 6 concerning the regulation of medication used in abortions was debated, with concerns raised about its potential implications on women's health rights and judicial protections for healthcare providers. The meeting included a robust exchange of views, reflecting a wide array of stakeholder interests including public health and law enforcement.
US
Transcript Highlights:
  • Makary, it does not matter who the next FDA commissioner is.
Summary: The meeting primarily focused on various executive nominations and their implications on labor and health affairs. Significant discussions surrounded the nomination of Mr. Sonderling as the Deputy Secretary of Labor, with members expressing concerns about workforce cuts affecting veterans and Social Security employees. There was also a debate led by a member regarding the authority and influence of private individuals, specifically citing Elon Musk's involvement in government decisions. Such discussions raised questions about transparency and accountability within governmental agencies, leading to a proposal for Mr. Musk to provide testimony before the committee.
TX

Texas 2025 - 89th Regular

State Affairs Mar 3rd, 2025

Senate State Affairs Committee

Transcript Highlights:
  • The FDA has received adverse reports involving Delta-8, and Delta-8 has not been evaluated or approved
  • If these products are medicinal, they should go through the FDA approval process.
  • If these products are considered medicine, then the FDA
  • We are being asked for purity that is multiple times what the FDA requires from their most stringent
  • Senators here that CBD has been FDA approved.
Summary: The meeting of the Senate State Affairs Committee provided a platform for discussing a comprehensive agenda featuring multiple bills, particularly focusing on concerns surrounding THC regulations and its implications for public safety. Notably, Senate Bill 3, which seeks to ban consumable hemp products containing THC, drew strong public testimony from various stakeholders who expressed both support and opposition. Supporters argued the necessity to curb the proliferation of high-potency THC products in schools and among youths, while opponents warned of the potential negative economic impacts and push towards unregulated markets if such a ban were implemented.
TX

Texas 2025 - 89th Regular

Public Health Mar 31st, 2025 at 08:03 am

House Public Health Committee

Transcript Highlights:
  • Sure, so there are two that are FDA approved.
  • The other FDA-approved emergency contraception is ulipristal acetate, and that is third...
  • So, the first drug that's FDA approved, you said it's Plan B, I can research that.
  • Contraception approved by FDA.
  • I believe the only FDA approved IUD is the copper

Summary: The public health committee meeting convened to discuss a variety of bills aimed at improving health-related policies in Texas. Noteworthy discussions included House Bill 1887, which seeks to enhance access to birth certificates for adult adoptees, and House Bill 754, which mandates medical assistance personnel to complete training on human trafficking. Both bills received positive support from the members present, and there were assurances that the bills would be reported favorably to the full House. Public testimony was also encouraged, allowing stakeholders to voice their opinions on these significant pieces of legislation.
TX

Texas 2025 - 89th Regular

State Affairs Apr 25th, 2025 at 08:04 am

House State Affairs Committee

Transcript Highlights:
  • It has been FDA-approved for 25 years and has continuously proven to be safe by institutions such as
  • According to the FDA, several U.S. women who used the abortion pill died due to overwhelming total body
  • As mentioned earlier, a 2016 study found that the FDA no longer...
  • The FDA warns that drugs from outside the U.S. supply chain
  • Non-FDA drugs are illegal. Giving someone drugs without their consent is illegal.
Summary: The committee meeting featured intense discussions surrounding HB5510 and HB229, both of which generated significant public testimony. Various witnesses expressed strong opposition to HB5510, particularly highlighting concerns over its potential to threaten equitable access to healthcare and its implications for women's rights. Testimonies revealed the emotional weight behind these bills, with speakers advocating for compassion towards vulnerable populations rather than punitive measures. The atmosphere was emotionally charged, as proponents and opponents alike provided firsthand accounts and perspectives that underscored the complexities surrounding these legislative issues. In contrast to the discussions on HB5510, commentary on HB229 mainly revolved around defining gender and safeguarding women's spaces. Many witnesses emphasized the bill's potential discriminatory effects on transgender and non-binary individuals, arguing that the legislation could fracture community relations rather than promote safety and dignity for all. Ultimately, despite the passion displayed in rebuttals from both sides, the meeting concluded with some bills left pending, leaving room for further consideration and debate in the future.
TX

Texas 2025 - 89th Regular

Health and Human Services Apr 8th, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • And one last thing on numbers: FDA regulations for

  • You're trying to fall under that three thousand of FDA so you don't have to test your birds for Salmonella
  • There are no requirements that FDA guidelines or CDC guidelines have to be followed. No FDA, no...
Summary: The meeting of the Senate Committee on Health and Human Services primarily focused on several pieces of legislation aimed at improving mental health care in Texas, especially for vulnerable populations. Notable discussions were held around SB719, which seeks to conduct a comprehensive assessment of inpatient psychiatric bed capacity in Texas, addressing the significant shortages faced by facilities. There was widespread support from committee members and public testimonies praising the need for improved mental health resources and proactive measures to enhance service delivery. Witnesses highlighted the critical situation surrounding mental health admissions, emphasizing the human impact of ongoing bed shortages and the tragic consequences for patients awaiting treatment.
US
Transcript Highlights:
  • The gap between when the FDA says this is a good product

  • It took five more years for the US FDA to approve the device that would save lives, it turns out, with
  • to create life-saving tools by aligning when the FDA approves
  • One of the things that I've emphasized is the importance of getting faster coverage through the FDA for
Summary: The committee convened to discuss critical issues surrounding the nomination of Michael Falkender for the position of Deputy Secretary of the Treasury. This meeting included a series of remarks from committee members who expressed divergent views on Falkender's qualifications and the implications of his appointment. Senator Wyden voiced strong opposition, arguing that Falkender represents harmful policies expected to be perpetuated under the current administration, especially concerning taxpayer privacy and IRS tactics. Meanwhile, other members defended Falkender, noting his extensive experience, including a commitment to transparency in government operations if confirmed.
TX

Texas 2025 - 89th Regular

S/C on Disease Prevention & Women's & Children's Health Mar 27th, 2025 at 08:00 am

House S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • There are currently eight FDA-approved medications for Duchenne, including exon skipping infusions, steroids
  • made considerable progress through the successful completion of multiple pilot programs, utilizing an FDA-approved
Summary: In this committee meeting, members engaged in extensive discussions regarding several bills aimed at enhancing public health initiatives in Texas. Notably, House Bill 1295 was introduced to tackle the pressing issue of health literacy, highlighting its critical importance for improving health outcomes and reducing costs within the state's healthcare system. Vice Chair Busey presented House Bill 321, which aims to streamline the enrollment process for Medicaid and CHIP by utilizing data from the SNAP application to ensure that eligible children can access necessary healthcare coverage. Both bills received public testimonies that emphasized the need for better health education and access to health insurance, particularly for children and vulnerable populations in Texas. Witnesses spoke on the societal importance of nurturing a health-conscious generation, thereby laying a moral obligation on policymakers to support such legislative endeavors.
TX

Texas 2025 - 89th Regular

Education K-16 Mar 18th, 2025

Senate Education K-16 Committee

Transcript Highlights:
  • It would ensure the law encompasses all FDA-approved epinephrine delivery methods, including current
  • They said FDA medication is safe. Thank you.
Summary: The Senate Education Committee convened to discuss multiple bills, primarily focusing on SB1619 and SB6019. Senator Dean Zaffirini presented SB1619, and the discussion revolved around modernizing the state's approach to epinephrine delivery devices. The highlighted importance of addressing anaphylaxis treatments in schools, particularly focusing on ensuring that both current and future delivery methods are adequately represented in the legislation was prominent. Participation from public testimony was also anticipated, allowing for community engagement.
TX

Texas 2025 - 89th Regular

Senate Session (Part II) May 15th, 2025

Texas Senate Floor Meeting

Bills: HB11, HB12, HB21, HB26, HB30, HB33, HB37, HB45, HB210, HB303, HB630, HB879, HB1041, HB1188, HB1261, HB1318, HB1465, HB1535, HB1593, HB1778, HB2559, HB2596, HB2692, HB2703, HB2712, HB2742, HB2809, HB2890, HB3012, HB3526, HB5061, HB5092, HB5238, HCR92, SB203, SB317, SB393, SB397, SB644, SB731, SB801, SB867, SB913, SB1071, SB1073, SB1086, SB1087, SB1250, SB1310, SB1359, SB1444, SB1483, SB1705, SB1782, SB1861, SB1897, SB1944, SB2023, SB2043, SB2082, SB2133, SB2215, SB2309, SB2497, SB2532, SB2549, SB2566, SB2617, SB2639, SB2696, SB2717, SB2747, SB2751, SB2790, SB2797, SB2799, SB2841, SB2850, SB2857, SB2891, SB2919, SB2928, SB2994, SB3051, SJR34, SB529, SB541, SB693, SB963, SB1968, SB2308, SB2544, SB1173, SB1646, SB1734, SB1833, SB1, SB17, SB260, SB509, SB1506, SB1637, HB1393, HB2559, HB26, HB3012, HB1593, HB2607, HB3526, HB3810, HB388, HB879, HB12, HB2703, HB30, HB2712, HB2692, HB1633, HB1318, HB685, HB630, HB4753, HB2742, HB303, HB198, HB1535, HB762, HB148, HB1520, HB5061, HB2286, HB1606, HB1041, HB132, HB11, HB45, HB48, HB1261, HB1465, HB1778, HB2596, HB5238, HB33, HB1188, HB210, HB1022, HB1458, HB5560, HB1240, HB1950, HB2027, HB2768, HB2788, HB2791, HB3146, HB3698, HB3699, HB1893, HB3700, HB4850, HB4187, HB1397, HB4885, HB4804, HB3751, HB3611, HB2775, HB2061, HB2003, HB1729, HB1242, HB791, HB2029, HB647, HB2522, HB4738, HB3033, HB3594, HB3474, HB2563, HB2802, HCR90, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB128, SB2043, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB511, SB2309, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB2891, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB2994, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1861, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2799, SB2688, SB2522, SB2639, SB2459, SB2655, SB2251, SB1884, SB2617, SB2928, SB2566, SB1897, SB1749, SB2549, SB2553, SB2919, SB1782, SB1705, SB2696, SB1944, SB2215, SB1232, SB2850, SB2969, SB2497, SB1798, SB2603, SB2607, SB781, HB34, HB128, HB130, HB581, HB668, HB677, HB766, HB2259, HB2960, HB2358, HB2894, HB4384, HB2663, HB748, HB793, HB1193, HB1734, HB2340, HB2350, HB3104, HB5180, HB4739, HB1584, HB4344, HB4238, HB4219, HB3806, HB3805, HB3804, HB3803, HB3229, HB3228, HB1922, HB1522, HB431, HB3597, HB1612, HB4224, HB754, HB1314, HB2254, HB2789, HB3560, HB4643, HB1237, HCR98, SB3070, SB835, SB524, SB2233, SB2683
Summary: In this committee meeting, significant legislative activities were undertaken, notably involving the discussion and passage of various bills. The most highlighted was SB2994, which focuses on energy efficiency goals and public participation in energy markets. Senator Johnson presented amendments to ensure the program's sustainability under variable market conditions, which garnered bipartisan support and passed with a majority. Additionally, SB2617 aimed at preserving historical references in education, which sparked discussions around curriculum integrity and the importance of traditional date formats in teaching methodology, highlighting community concerns regarding educational content changes. The meeting was well-managed, allowing for thorough examination of each bill amidst a respectful exchange of perspectives from both supporters and dissenters.
TX

Texas 2025 - 89th Regular

Senate Session (Part I) May 15th, 2025

Texas Senate Floor Meeting

Bills: HB11, HB12, HB21, HB26, HB30, HB33, HB37, HB45, HB210, HB303, HB630, HB879, HB1041, HB1188, HB1261, HB1318, HB1465, HB1535, HB1593, HB1778, HB2559, HB2596, HB2692, HB2703, HB2712, HB2742, HB2809, HB2890, HB3012, HB3526, HB5061, HB5092, HB5238, HCR92, SB203, SB317, SB393, SB397, SB644, SB731, SB801, SB867, SB913, SB1071, SB1073, SB1086, SB1087, SB1250, SB1310, SB1359, SB1444, SB1483, SB1705, SB1782, SB1861, SB1897, SB1944, SB2023, SB2043, SB2082, SB2133, SB2215, SB2309, SB2497, SB2532, SB2549, SB2566, SB2617, SB2639, SB2696, SB2717, SB2747, SB2751, SB2790, SB2797, SB2799, SB2841, SB2850, SB2857, SB2891, SB2919, SB2928, SB2994, SB3051, SJR34, SB529, SB541, SB693, SB963, SB1968, SB2308, SB2544, SB1173, SB1646, SB1734, SB1833, SB1, SB17, SB260, SB509, SB1506, SB1637, HB1393, HB2559, HB26, HB3012, HB1593, HB2607, HB3526, HB3810, HB388, HB879, HB12, HB2703, HB30, HB2712, HB2692, HB1633, HB1318, HB685, HB630, HB4753, HB2742, HB303, HB198, HB1535, HB762, HB148, HB1520, HB5061, HB2286, HB1606, HB1041, HB132, HB11, HB45, HB48, HB1261, HB1465, HB1778, HB2596, HB5238, HB33, HB1188, HB210, HB1022, HB1458, HB5560, HB1240, HB1950, HB2027, HB2768, HB2788, HB2791, HB3146, HB3698, HB3699, HB1893, HB3700, HB4850, HB4187, HB1397, HB4885, HB4804, HB3751, HB3611, HB2775, HB2061, HB2003, HB1729, HB1242, HB791, HB2029, HB647, HB2522, HB4738, HB3033, HB3594, HB3474, HB2563, HB2802, HCR90, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB128, SB2043, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB511, SB2309, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB2891, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB2994, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1861, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2799, SB2688, SB2522, SB2639, SB2459, SB2655, SB2251, SB1884, SB2617, SB2928, SB2566, SB1897, SB1749, SB2549, SB2553, SB2919, SB1782, SB1705, SB2696, SB1944, SB2215, SB1232, SB2850, SB2969, SB2497, SB1798, SB2603, SB2607, SB781, HB34, HB128, HB130, HB581, HB668, HB677, HB766, HB2259, HB2960, HB2358, HB2894, HB4384, HB2663, HB748, HB793, HB1193, HB1734, HB2340, HB2350, HB3104, HB5180, HB4739, HB1584, HB4344, HB4238, HB4219, HB3806, HB3805, HB3804, HB3803, HB3229, HB3228, HB1922, HB1522, HB431, HB3597, HB1612, HB4224, HB754, HB1314, HB2254, HB2789, HB3560, HB4643, HB1237, HCR98, SB3070, SB835, SB524, SB2233, SB2683
Summary: During the committee meeting, several bills were thoroughly discussed, leading to key legislative advancements. Notably, HB30, which relates to property tax calculations during disasters, received final passage after amendments were proposed and debated, highlighting the ongoing concern over the management of tax rates amid emergency situations. Senators expressed the importance of fiscal responsibility while also addressing the need for appropriate tax relief for affected areas. Additionally, SB835, concerning confidentiality provisions related to acts of sexual abuse, was passed unanimously, demonstrating a strong bipartisan commitment to supporting victims and ensuring their rights to speak out without fear of retribution.
TX

Texas 2025 - 89th Regular

Senate Session (Part II) May 28th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • of last things, the House included language if the United States Food and Drug Administration, the FDA
  • The goal of which is if we can get enough states moving on this, I think that we can reform our FDA and
Bills: HB4, HB20, HB40, HB46, HB101, HB112, HB117, HB121, HB127, HB146, HB150, HB186, HB229, HB426, HB521, HB541, HB549, HB632, HB713, HB796, HB1052, HB1106, HB1135, HB1234, HB1306, HB1403, HB1523, HB1532, HB1690, HB1960, HB2035, HB2217, HB2399, HB2488, HB2517, HB2594, HB2655, HB2686, HB2731, HB2757, HB2820, HB2963, HB3005, HB3053, HB3073, HB3225, HB3320, HB3333, HB3336, HB3441, HB3483, HB3516, HB3520, HB3697, HB3748, HB3793, HB3848, HB4099, HB4134, HB4144, HB4158, HB4233, HB4236, HB4285, HB4350, HB4359, HB4464, HB4580, HB4690, HB4730, HB4848, HB4904, HB4995, HB5196, HB5294, HB5381, HB5435, HB5437, HB5509, HB5606, HB5646, HB5658, HB5661, HB5663, HB5666, HB5672, HCR40, HCR59, SB867, SB2919, SJR5, SJR27, SB4, SB6, SB7, SB9, SB13, SB15, SB23, SB27, SB30, SB40, SB57, SB66, SB140, SB268, SB293, SB331, SB413, SB447, SB457, SB467, SB506, SB510, SB512, SB571, SB650, SB763, SB777, SB785, SB800, SB850, SB863, SB865, SB973, SB974, SB1191, SB1281, SB1300, SB1362, SB1494, SB1522, SB1540, SB1567, SB1579, SB1580, SB1610, SB1660, SB1723, SB1760, SB1838, SB1923, SB1946, SB1957, SB1964, SB2018, SB2024, SB2121, SB2167, SB2217, SB2221, SB2321, SB2337, SB2368, SB2373, SB2407, SB2431, SB2477, SB2587, SB2615, SB2753, SB2807, SB2900, SB2965, SB2972, SB2986, SB3039, SB3047, SB3059, SB3070, SB1, SB17, SB21, SB260, SB379, SB509, SB1198, SB1405, SB1506, SB1637, SB1833, SB2155, SB2308, SB2601, SB2778, HB300, HB2011, HB2525, HB5246, HB100, HB101, HB119, HB227, HB252, HB322, HB346, HB654, HB705, HB718, HB721, HB824, HB1094, HB1234, HB1306, HB1506, HB1523, HB1629, HB1690, HB1868, HB1960, HB1973, HB2012, HB2035, HB2037, HB2078, HB2128, HB2213, HB2240, HB2348, HB2520, HB2598, HB2686, HB2694, HB2820, HB3005, HB3057, HB3092, HB3112, HB3171, HB3181, HB3185, HB3333, HB3388, HB3516, HB3546, HB3619, HB3623, HB3629, HB3642, HB3686, HB3697, HB3749, HB3793, HB3812, HB3815, HB3848, HB3909, HB4081, HB4145, HB4157, HB4158, HB4170, HB4202, HB4211, HB4214, HB4233, HB4285, HB4350, HB4361, HB4463, HB4464, HB4466, HB4559, HB4630, HB4748, HB4765, HB4848, HB4894, HB4904, HB4995, HB5093, HB5196, HB5320, HB5437, HB5624, HB5650, HB5651, HB5652, HB5654, HB5655, HB5656, HB5658, HB5661, HB5662, HB5664, HB5665, HB5666, HB5670, HB5672, HB5674, HB5677, HB5679, HB5682, HB5689, HB5690, HB5694, HB5695, HB5698, HB5699, HCR46, HCR76, HCR81, HCR83, HCR84, HCR111, HB748, HB5652, HB3395, HB180, HB1306, HB5650, HB4894, HB1629, HB5698, HB3171, HB2694, HB5664, HB4690, HB4464, HB3623, HB2520, HB2213, HB252, HB146, HB5596, HB3619, HB5320, HB5651, HB5670, HB5665, HB5437, HB5679, HB5661, HB5662, HB5654, HB5672, HB5656, HB2035, HB721, HB346, HB5695, HB5694, HB5674, HB3185, HB2348, HB1135, HB101, HB5666, HB5677, HB5682, HB5658, HB4144, HB3642, HB3815, HB2686, HB2012, HB1960, HB227, HB654, HB4158, HB4630, HB1523, HB1973, HB3333, HB3697, HB3546, HB3225, HB2820, HB186, HB119, HB4466, HB4170, HB3909, HB4081, HB4145, HB4285, HB4463, HB4995, HB5624, HB1449, HB2598, HB3629, HB4361, HB824, HB1868, HB4848, HB40, HB117, HB3686, HB3793, HB112, HB104, HB718, HB4904, HB4202, HB4765, HB4559, HB4350, HB4214, HB3388, HB3112, HB5196, HB3516, HB3092, HB4233, HB1094, HB2037, HB3005, HB3848, HB121, HB3336, HB5294, HB5646, HB4236, HB1052, HB5509, HB5435, HB3520, HB3320, HB2517, HB2488, HB5663, HB2731, HB3073, HB2655, HB2399, HB541, HB4099, HB111, HB1532, HB3483, HB2963, HB4580, HB3748, HB713, HB632, HB426, HB4730, HB127, HB5690, HB5689, HB5655, HB3385, HB2757, HB4359, HB5381, HB20, HB123, HB549, HB5606, HB2217, HB2594, HB796, HB1057, HB3664, HCR141, HCR40, HCR59, HCR76, HCR81, HCR46, HCR111, HCR83, HCR84, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3045, SB3071, HB40, HB117, HB121, HB426, HB541, HB713, HB1052, HB1532, HB2217, HB2488, HB2517, HB2655, HB2757, HB2963, HB3073, HB3697, HB4099, HB4144, HB4158, HB4236, HB4285, HB4848, HB5435, HB5437, HB5509, HB5646, HB5666, HB14, HB1240, HB796, HB1523, HB5294, SR559, SR587, SR614, SCR53, SJR59, SB10, SB22, SB25, SB34, SB36, SB38, SB261, SB777, SB924, SB1188, SB1318, SB1333, SB1398, SB1448, SB1621, SB1862, SB2405, SB2406, SB8, SB12, SB37, SB441, SB1566, SB2878, HB300, HB2011, HB5246, HB101, HB119, HB227, HB252, HB346, HB654, HB718, HB721, HB824, HB1306, HB1629, HB1868, HB1960, HB1973, HB2012, HB2035, HB2037, HB2213, HB2348, HB2520, HB2598, HB2686, HB2694, HB2820, HB3005, HB3092, HB3112, HB3185, HB3333, HB3388, HB3516, HB3546, HB3619, HB3623, HB3629, HB3642, HB3686, HB3815, HB3848, HB3909, HB4081, HB4145, HB4170, HB4202, HB4214, HB4350, HB4361, HB4463, HB4464, HB4466, HB4559, HB4630, HB4765, HB4894, HB4904, HB4995, HB5196, HB5320, HB5624, HB5650, HB5651, HB5652, HB5654, HB5655, HB5656, HB5658, HB5661, HB5662, HB5664, HB5665, HB5670, HB5672, HB5674, HB5677, HB5679, HB5682, HB5695, HB5698, HCR46, HCR76, HCR81, HCR83, HCR84, HCR111, HB1094, HB3171, HB3793, HB4233, HB5689, HB5690, HB5694
Summary: In this meeting, the committee focused on a crucial set of bills addressing various legislative issues. Notably, there were discussions surrounding HB2488, which seeks to modernize the Texas Workers' Compensation dispute resolution process by authorizing remote hearings. Senators voiced their support for the bill, citing its potential to streamline operations. Additionally, HB2011 was significant as it enables property owners to repurchase property lost through eminent domain under specific conditions. The motion to establish a conference committee on this bill was readily accepted without objection. Furthermore, the committee engaged in several discussions regarding amendments proposed by the House to various Senate bills, highlighting the importance of collaboration between chambers.
TX
Transcript Highlights:
  • medical doctor writing an order for the patient, and it is a practice outlined and approved by the FDA
  • Blood centers are licensed by the FDA, and part of being compliant with federal regulations is that the
Summary: The meeting of the Public Health Committee focused on several significant bills concerning blood donation practices and patient care. Notably, Senate Bill 125 faced opposition from multiple testimonies that raised concerns about the potential risks associated with directed donations. Testimony from representatives of the blood centers highlighted alarming statistics about the increased incidence of infectious diseases among directed donors, urging the committee to reconsider the bill's implications. Supporters of the bill argued for the necessity of such provisions to protect patients with rare blood types, stressing the importance of ensuring their access to appropriate care. As discussions unfolded, the challenges of maintaining a balanced blood supply while accommodating specific patient needs became a central theme.
TX

Texas 2025 - 89th Regular

Insurance Mar 19th, 2025 at 10:30 am

House Insurance Committee

Transcript Highlights:
  • They're allowed to pull from peer-reviewed studies from FDA studies.
Bills: HB138, HB335, HB388
Summary: The meeting of the committee focused significantly on discussions surrounding HB138 and HB388. Representative Harris-DeVille presented HB388, which aims to standardize the coordination of benefits questionnaires used by health benefit plan issuers and healthcare providers. This discussion highlighted the issues of patient billing complexities and the potential for reduced errors in healthcare coverage. Various stakeholders provided testimony in support of the bill, emphasizing its importance in streamlining the process for patients who have dual coverage, such as Medicaid and Medicare. There was considerable backing for the functionality that HB388 would bring in clearing up confusion in billing practices across different insurance plans.
US
Transcript Highlights:
  • ...on healthcare competition, FDA policy, public health, and
Summary: The meeting was chaired by Chairman Schweikert and involved a comprehensive discussion on how to utilize artificial intelligence (AI) for reducing waste, fraud, and improper payments within federal programs. Key witnesses, including Mr. Andrew Canarsa from the Council of the Inspectors General, provided insights on the potential of AI in enhancing government efficiency. The committee emphasized the importance of reliable data and thorough examination of AI application to avoid unintended consequences while addressing the estimated $162 billion in improper payments reported by the federal government. Concerns were raised regarding the recent firing of inspectors general and the impacts that could have on oversight and accountability processes.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 26th, 2025 at 10:05 am

Texas House Floor Meeting

Transcript Highlights:
  • How would the law work with the rules of the FDA?

  • These rules conflict at all with FDA rules?
  • The FDA on their website has this statement.
  • compliant and have not been approved by the FDA, the amendment references FDA approved products and
  • On May 8, 2025, the chairman of the FDA,...

Bills: SB6, SB30, SB13, SB2878, SB2501, SB66, SB268, SB331, SB618, SB414, SB1394, SB2425, SB898, SB993, SB442, SB735, SB784, SB2538, SB1919, SB1013, SB2215, SB2322, SB626, SB570, SB747, SB2183, SB673, SB1015, SB1447, SB1370, SB1784, SB1897, SB2873, SB2891, SB2933, SB2540, SB2681, SB2695, SB1965, SB2203, SB872, SB875, SB1030, SB1277, SB1730, SB1681, SB1152, SB2969, SB2747, SB2705, SB2541, SB1708, SB2080, SB2721, SB1986, SB2392, SB2539, SB2857, SB2799, SB2785, SB2782, SB1531, SB1927, SB1263, SB1098, SB835, SB3070, SB22, SJR27, SB25, SB7, SB552, SB1612, SJR87, SJR1, SB6, SB30, SB13, SB2878, SB57, SB127, SB293, SB441, SB3059, SB512, SB241, SB1718, SB140, SB2055, SB2075, SB2018, SB1534, SB1567, SB785, SB1233, SB1580, SB1663, SB413, SB447, SB519, SB467, SB1579, SB1191, SB1021, SB1838, SB2807, SB2835, SB546, SB2121, SB2167, SB2035, SB2024, SB1032, SB1049, SB1266, SB1400, SB1302, SB401, SB1596, SB1281, SB1242, SB1343, SB310, SB1346, SB2753, SB2703, SB2221, SB1719, SB2177, SB800, SB790, SB748, SB571, SB1957, SB1923, SB1896, SB1760, SB1335, SB2368, SB2477, SB2587, SB2972, SB2986, SB2965, SB1563, SB1467, SB1164, SB1137, SB614, SB705, SB961, SB918, SB955, SB869, SB850, SB863, SB1610, SB1055, SB2206, SB457, SB2337, SB1362, SB926, SB1494, SB251, SB456, SB500, SB1307, SB2615, SB2995, SB2321, SB973, SB974, SB865, SB506, SB781, SB1522, SB1558, SB510, SB667, SB763, SB2073, SB1858, SB1660, SB505, SB2900, SB1433, SB1540, SB1964, SB1300, SB1644, SB2217, SB2373, SB2431, SB1758, SB2480, SB3039, SB3047, SB3073, SB2920, SB2781, SB826, SB766, SB2460, SB527, SB1946, SB2885, SB1243, SB2610, SB2595, SB857, SB2501, SB66, SB268, SB331, SB618, SB414, SB1394, SB2425, SB898, SB993, SB442, SB735, SB784, SB2538, SB1919, SB1013, SB2215, SB2322, SB626, SB570, SB747, SB2183, SB673, SB1015, SB1447, SB1370, SB1784, SB1897, SB2873, SB2891, SB2933, SB2540, SB2681, SB2695, SB1965, SB2203, SB872, SB875, SB1030, SB1277, SB1730, SB1681, SB1152, SB2969, SB2747, SB2705, SB2541, SB1708, SB2080, SB2721, SB1986, SB2392, SB2539, SB2857, SB2799, SB2785, SB2782, SB1531, SB1927, SB1263, SB1098, SCR9, HB5560, HB762, HB107, HB114, HB138, HB4386, HB2495, HB581, HB3348, HB5323, HB1584, HB4341, HB6, HB171, HB143, HB449, HB3486, HB4263, HB5246, HB2, HB2011, SB17, SB21
Summary: The meeting included discussions on various bills focusing on education regulations, public safety, and funding for events. One notable debate centered around SB1718, which proposed using taxpayer dollars to fund the NRA's convention. Representative Goodwin delivered a passionate speech against the bill, linking the discussion to recent tragedies in Uvalde and raising concerns about the appropriateness of state support for groups perceived as politically motivated. The legislation prompted strong reactions from both sides, highlighting the polarized views on gun laws and public security. Additionally, amendments to bills concerning educational materials were deliberated, with amendments proposed to ensure context is considered before banning books from libraries. The committee also advanced several key public safety measures, particularly addressing judicial security in response to threats faced by judges. The meeting was well-attended, with members actively engaging in discussions and public testimonies reflecting a variety of perspectives on the proposed legislation.
TX

Texas 2025 - 89th Regular

Agriculture & Livestock Apr 1st, 2025 at 02:00 pm

House Agriculture & Livestock Committee

Transcript Highlights:
  • Food and Drug Administration, or FDA, on multiple occasions.
  • By the way, the FDA does not require a hands-on initial exam unless it's...
  • Both the FDA and the USDA require an in-person exam to develop a VCPR to be able to diagnose, treat,
  • span>

    Okay, so I guess what I'm trying to say is that the FDA

Summary: The second bill, House Bill 3469, was introduced to address pest control regulations concerning nuisance birds. Representative Campos explained how the bill proposes non-lethal methods to deter these birds, such as the use of laser lights and sounds, which avoids conflict with both state and federal regulations. The committee heard impassioned testimonies from members of the public who shared firsthand experiences regarding the adverse effects of these birds on property and public health. The meeting concluded with both bills being left pending, reflecting a desire for further deliberation among the committee members.
TX
Transcript Highlights:
  • We cannot have synthetic drugs with no kind of medical review, FDA review, or any oversight on the market—products
Summary: The meeting centered on the Texas Compassionate Use Program (T-CUP) and recent legislative changes, primarily focusing on HB46, which aims to improve accessibility and regulations within the program for medical cannabis. Senator Roland Gutierrez expressed continued support for the T-CUP, underscoring the importance of ensuring safety for minors and regulating the untested hemp products on the market. He highlighted the need for a more robust framework to mitigate risks posed by synthetic cannabinoids and to protect patients relying on the program, particularly veterans and individuals with chronic illnesses. Discussions revealed a bipartisan commitment to enhancing T-CUP, though challenges persist regarding the oversight of hemp production and sales.

Research Filters

States
Terms / Sessions
Date Range
Chamber Records
Meetings / Events / Calendars